TrialKidney international2021

EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.

Kathleen M Hill Gallant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.